Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

THYROCARE TECHNOLOGIES Gains 4%; BSE HEALTHCARE Index Up 0.3%
Tue, 13 Aug 13:3

THYROCARE TECHNOLOGIES Gains 4%; BSE HEALTHCARE Index Up 0.3%Image source: phive2015/www.istockphoto.com

THYROCARE TECHNOLOGIES share price has zoomed 4% and is presently trading at Rs 870.6.

Meanwhile, the BSE HEALTHCARE index is at 41,168.9 (up 0.3%).

Among the top gainers in the BSE HEALTHCARE index today are FORTIS HEALTHCARE (up 4.7%) and Aurobindo Pharma (up 4.4%).

Cadila Healthcare (down 5.2%) and ALEMBIC PHARMA (down 2.7%) are among the top losers today.

Over the last one year, THYROCARE TECHNOLOGIES has moved up from Rs 571.7 to Rs 870.6, registering a gain of Rs 298.9 (up 52.3%).

On the other hand, the BSE HEALTHCARE index has moved up from 28,485.8 to 41,168.9, registering a gain of 44.5% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were Jubilant Pharmova (up 110.8%), GRANULES INDIA (up 110.7%) and SUVEN PHARMACEUTICALS (up 105.2%).

Must See: These Segments are Witnessing Incredible Growth with Modi's Push

What About the Benchmark Indices?

The BSE Sensex is at 79,278.4 (down 0.5%).

The top losers among the BSE Sensex today are HDFC Bank (down 2.7%) and Tata Motors (down 1.9%). The most traded stocks in the BSE Sensex are Tata Steel and HDFC Bank.

In the meantime, NSE Nifty is at 24,234.3 (down 0.5%). HDFC Bank and HDFC LIFE INSURANCE are among the top losers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 65,995.8 to 79,278.4, registering a gain of 13,282.6 points (up 20.1%).

THYROCARE TECHNOLOGIES Financial Update...

THYROCARE TECHNOLOGIES net profit grew 41.9% YoY to Rs 243 million for the quarter ended June 2024, compared to a profit of Rs 171 million a year ago. Net sales rose 16.3% to Rs 1,569 million during the period as against Rs 1,349 million in April-June 2023.

For the year ended March 2024, THYROCARE TECHNOLOGIES reported 8.0% increase in net profit to Rs 695 million compared to net profit of Rs 644 million during FY23. Revenue of the company grew 8.6% to Rs 5,719 million during FY24.

The current Price to earnings ratio of THYROCARE TECHNOLOGIES, based on rolling 12 month earnings, stands at 60.4.


Equitymaster requests your view! Post a comment on "THYROCARE TECHNOLOGIES Gains 4%; BSE HEALTHCARE Index Up 0.3%". Click here!